Trametinib with or without Vemurafenib in BRAF Mutated Non-Small Cell Lung Cancer
Monika Joshi(Pennsylvania State University), Chandra P. Belani(Pennsylvania State University)
Cited by 61
Related Papers
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group
|Journal of Clinical Oncology|2003|943
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer
|Journal of Thoracic Oncology|2020|184
Phase I and Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients with Refractory Advanced Cancers
|Clinical Cancer Research|2007|87